This web site was copied prior to January 20, 2005. It is now a Federal record managed by the National Archives and Records Administration. External links, forms, and search boxes may not function within this collection.
This program enhances the effectiveness of postmarketing surveillance of medical
products as they are used in clinical practice and rapidly identifies significant
health hazards associated with these products. Visit the MedWatch page
and learn how to work with your health care professional to report possible
adverse reactions. The identity of the patient is kept confidential.
"MedWatch: FDA's 'Heads
Up' on Medical Product Safety"
An FDA Consumer article discussing the MedWatch program to improve
the safety of drugs, biologics, medical devices, dietary supplements, medical
foods, infant formulas, and other regulated products by encouraging health
care professionals to report serious adverse events and product defects. (November-December
Current HIV treatment
The U.S. Department of Health and Human Services issues guidance documents
for the medical management of HIV infection and other issues surrounding HIV
infection. Includes guidelines for antiretroviral treatment, maternal-child
transmission, post-exposure prophylaxis, management of HIV complications,
testing, and archived guidelines.